查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1503440

到 2030 年医疗食品市场预测：按产品、给药途径、销售管道、营养成分、形式、年龄层、应用和地区进行全球分析

Medical Foods Market Forecasts to 2030 - Global Analysis By Product, Route of Administration, Sales Channel, Nutritional Ingredient, Form, Age Group, Application and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2024 年全球医疗食品市场价值为 276.2 亿美元，预计在预测期内将以 8.2% 的复合年增长率增长，到 2030 年将达到 443.1 亿美元。

医疗食品是专门为疾病和病症的饮食管理而配製的产品，这些疾病和病症具有独特的营养需求，仅靠常规饮食无法满足。与膳食食品不同，医用食品需要在医疗监督下使用，通常用于特定的医疗状况，例如代谢紊乱、胃肠道疾病或神经系统疾病。医疗食品是根据科学原理配製的，以确保您根据个人情况获得所需的准确营养量。

据世界卫生组织 (WHO) 称，2015 年至 2050 年间，全球 60 岁及以上人口预计将翻一番，从 12% 增至 22%。根据国际糖尿病联盟的数据，2019 年约有 4.63 亿成年人患有糖尿病，预计到 2045 年将增加至 7 亿。

代谢性疾病增加

糖尿病、苯酮尿症和各种先天性代谢缺陷等代谢性疾病的增加正在显着推动医疗食品市场的成长。这些疾病需要精确的饮食管理来控制症状并预防併发症，从而增加了对专门为满足受影响个体的营养需求而设计的医疗食品的需求。此外，医疗保健专业人员和患者对营养在代谢紊乱管理中的作用的认识不断提高，也有助于医疗食品市场的扩大。

认识和采用有限

认识和采用有限是医疗食品市场的主要限制。许多医疗保健专业人员和患者经常对什么是医疗食品、它们与常规食品和药物有何不同以及医疗食品在治疗慢性疾病和医疗状况方面的具体用途感到困惑。这种认识的缺乏可能会导致利用不足和怀疑，因为医用食品通常需要医疗监督并遵守严格的使用指南。此外，教育和行销力度不足也导致采用率低。

个人化营养

医疗食品市场透过根据个人健康需求客製化饮食干预措施，为个人化营养提供了重要机会。个人化营养着重于根据人的遗传、微生物组、生活方式和健康状况开发客製化饮食。这种方法可以加强慢性病管理，改善患者的治疗效果，并满足特定的代谢需求。随着医疗保健日益转向精准医疗，个人化医疗食品可以提供有针对性的营养解决方案，以减少对药物的依赖并优化整体健康。

市场竞争

医疗食品市场面临多方面的重大市场竞争威胁。製药公司凭藉先进的治疗营养产品进入该领域也将加剧竞争。此外，功效声明所需的临床试验的成本和复杂性也是新参与企业的障碍。监管变化和不断变化的报销政策可能会影响市场动态，有利于能够快速适应的现有企业。开发独特且有针对性的配方的创新压力也加剧了竞争。

COVID-19 的影响：

COVID-19 大流行在多个方面对医疗食品市场产生了重大影响。随着健康意识的增强，对支持免疫健康和整体健康的产品的需求激增。此外，全球供应链的中断正在为原材料采购和製造带来挑战。然而，电子商务平台和线上零售的进步在一定程度上缓解了这些挑战，使消费者能够更方便地获得医疗食品。

维生素和矿物质行业预计将在预测期内成为最大的行业

医疗食品市场维生素和矿物质部分的成长主要是由于人们对营养缺乏及其对健康影响的认识不断提高而推动的。随着人们健康意识的增强，对针对特定健康状况的有针对性的营养解决方案的需求不断增长。维生素和矿物质在支持多种身体功能方面发挥着重要作用，使其成为治疗营养不良、代谢紊乱和慢性疾病等疾病的医疗食品的重要成分。此外，研究和开发的进步导致了专门产品的配方以满足特定的营养需求，进一步推动了该领域的成长。

预计慢性病产业在预测期间内复合年增长率最高

医疗食品市场慢性病部分的成长归因于多种因素。糖尿病、心血管疾病和胃肠道疾病等慢性病的盛行率日益增加，推动了对专门营养品的需求，以有效管理这些疾病。医学研究的进步导致了专门为满足慢性病患者的营养需求而设计的创新配方的开发。此外，医疗保健专业人员和患者对营养在慢性病管理中的作用的认识不断提高，正在推动市场扩张。

比最大的地区

近年来，北美医疗食品市场经历了显着成长。这种扩张是由于多种因素造成的，包括人们越来越认识到营养疗法在治疗糖尿病、阿兹海默症和代谢紊乱等慢性疾病中的重要性。此外，医学研究和技术的进步也促进了针对特定健康状况的创新医疗食品的开发。此外，北美的老龄化人口正在增加对支持健康老化和管理与老龄化相关疾病的产品的需求。

复合年增长率最高的地区：

由于多种因素，亚太地区医疗食品市场正在经历显着成长。人们对健康和营养意识的提高、慢性病盛行率的增加以及人口老化正在推动对特种营养产品的需求。此外，医疗保健基础设施的进步和可支配收入的增加正在促进更多人获得医疗食品。此外，该地区多样化的饮食习惯和文化偏好鼓励产品开发创新，以满足特定的饮食需求。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 新兴市场
  • COVID-19 的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球医疗食品市场：副产品

  • 口服补液溶液
  • 营养全面的配方
  • 配方营养不完整

第六章 全球医疗食品市场：依管理途径

  • 口服
  • 肠内

第七章全球医疗食品市场：依销售管道

  • 超级市场/大卖场
  • 零售药房
  • 药局
  • 网上销售
  • 企业销售（医院药局）

第八章全球医疗食品市场：依营养成分分类

  • 蛋白质
  • 维生素和矿物质
  • 异黄酮
  • Omega-3
  • 植物固醇

第九章全球医疗食品市场：依形状分类

  • 酒吧
  • 凝胶
  • 液体
  • 粉末
  • 锭剂/胶囊
  • 其他形状

第十章全球医疗食品市场：依年龄组别

  • 成人
  • 青春期
  • 断乳期
  • 婴儿

第十一章全球医疗食品市场：依应用分类

  • 睡眠管理
  • 神经退化性疾病
  • 枫糖尿症(MSUD)
  • 糖尿病（糖尿病神经病变）
  • 癌症（化疗引起的腹泻）
  • 注意力不足过动症（ADHD）
  • 阿兹海默症
  • 慢性疾病
  • 忧郁症
  • 先天性代谢缺陷
  • 轻度肝性脑病变
  • 神经/心理疾病
  • 营养不良
  • 肥胖/高血压
  • 眼科
  • 病原体相关感染疾病
  • 尿素循环障碍
  • 罕见疾病
    • 嗜伊红性食道炎
    • 苯酮尿症
    • 食物蛋白诱发的小肠结肠炎症候群 (FPIES)
  • I/II型酪胺酸血症
  • 丙酸血症
  • 疼痛管理
  • 有机酸尿症
  • 甲基丙二酸血症
  • 异戊酸血症
  • 高胱氨酸尿症
  • 胃肠道疾病

第十二章全球医疗食品市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东/非洲

第十三章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购/合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十四章 公司概况

  • Abbott Laboratories
  • Ajinomoto Cambrooke Inc
  • Alfasigma SpA
  • BioMarin Pharmaceutical
  • Cerecin Inc
  • Danone SA
  • Fresenius SE & Co. KGaA
  • Mead Johnson
  • Meiji Holdings and Co Ltd
  • Metagenics Inc
  • Nestle SA
  • Primus Pharmaceuticals Inc
  • Reckitt Benckiser Group plc
Product Code: SMRC26611

According to Stratistics MRC, the Global Medical Foods Market is accounted for $27.62 billion in 2024 and is expected to reach $44.31 billion by 2030 growing at a CAGR of 8.2% during the forecast period. Medical foods are specially formulated products intended for the dietary management of diseases or conditions with distinctive nutritional needs that cannot be met by a normal diet alone. Unlike dietary supplements, medical foods are meant to be used under medical supervision and are often used for specific conditions like metabolic disorders, gastrointestinal diseases, or neurological disorders. They are formulated based on scientific principles to provide essential nutrients in precise amounts, tailored to the individual's condition.

According to the World Health Organization, the global population of people aged 60 and over is expected to double from 12 percent to 22 percent between 2015 and 2050. According to the International Diabetic Federation, around 463 million adults have diabetes in 2019, with this figure expected to climb to 700 million by 2045.

Market Dynamics:

Driver:

Rise in metabolic disorders

The rise in metabolic disorders, such as diabetes, phenylketonuria, and various inborn errors of metabolism, is significantly driving the growth of the medical food market. As these conditions require precise dietary management to control symptoms and prevent complications, there is an increasing demand for specialized medical foods designed to meet the nutritional needs of affected individuals. Additionally, greater awareness among healthcare professionals and patients about the role of nutrition in managing metabolic disorders contributes to the expanding market for medical foods.

Restraint:

Limited awareness and adoption

In the medical food market, limited awareness and adoption are significant restraints. Many healthcare professionals and patients are unfamiliar with what medical foods are, how they differ from regular foods and drugs, and their specific applications in managing chronic diseases or conditions. This lack of awareness can lead to underutilization and skepticism, as medical foods often require medical supervision and adherence to strict usage guidelines. Additionally, inadequate education and marketing efforts contribute to a slow adoption rate.

Opportunity:

Personalized nutrition

The medical food market offers significant opportunities in personalized nutrition by tailoring dietary interventions to individual health needs. Personalized nutrition focuses on developing customized diets based on a person's genetics, microbiome, lifestyle, and health conditions. This approach can enhance the management of chronic diseases, improve patient outcomes, and cater to specific metabolic requirements. As healthcare increasingly shifts towards precision medicine, personalized medical foods can provide targeted nutritional solutions, reducing reliance on pharmaceuticals and optimizing overall health.

Threat:

Market competition

The medical foods market faces significant market competition threats from several angles. Pharmaceutical companies entering the space with advanced therapeutic nutrition products also heighten competition. Additionally, the cost and complexity of clinical trials required for efficacy claims create barriers for new entrants. Regulatory changes and evolving reimbursement policies can impact market dynamics, favoring established players who can quickly adapt. Innovation pressure to develop unique, targeted formulations adds another layer of competitive intensity.

Covid-19 Impact:

The COVID-19 pandemic has significantly impacted the medical food market in several ways. With increased awareness of health and wellness, there has been a surge in demand for products that support immune health and overall well-being. Furthermore, disruptions in the global supply chain have led to challenges in sourcing ingredients and manufacturing. However, advancements in e-commerce platforms and online retailing have helped mitigate these challenges to some extent, enabling consumers to access medical foods conveniently.

The Vitamins and Minerals segment is expected to be the largest during the forecast period

The growth of the vitamins and minerals segment in the medical food market is primarily driven by increasing awareness of nutritional deficiencies and their impact on health. As people become more health-conscious, there's a growing demand for targeted nutritional solutions to address specific health conditions. Vitamins and minerals play crucial roles in supporting various bodily functions, making them essential components of medical foods designed to manage conditions like malnutrition, metabolic disorders, and chronic diseases. Moreover, advancements in research and development have led to the formulation of specialized products tailored to meet specific nutritional needs, further fueling segment growth.

The Chronic conditions segment is expected to have the highest CAGR during the forecast period

The growth in the chronic conditions segment of the medical food market can be attributed to several factors. The increasing prevalence of chronic diseases such as diabetes, cardiovascular disorders, and gastrointestinal ailments is driving demand for specialized nutrition tailored to manage these conditions effectively. Advancements in medical research have led to the development of innovative formulations specifically designed to address the nutritional needs of individuals with chronic illnesses. Additionally, rising awareness among both healthcare professionals and patients about the role of nutrition in managing chronic conditions is fuelling market expansion.

Region with largest share:

In recent years, North America has experienced significant growth in the medical food market. This expansion can be attributed to several factors, including increasing awareness about the importance of nutritional therapies in managing chronic diseases like diabetes, Alzheimer's, and metabolic disorders. Additionally, advancements in medical research and technology have led to the development of innovative medical food products tailored to address specific health conditions. Moreover, the aging population in North America has contributed to the rising demand for products that support healthy aging and manage age-related ailments.

Region with highest CAGR:

The Asia-Pacific region has witnessed significant growth in the medical food market due to several factors. Increasing awareness about health and nutrition, the rising prevalence of chronic diseases, and a growing aging population are driving the demand for specialized nutritional products. Additionally, advancements in healthcare infrastructure and rising disposable incomes are facilitating greater access to medical foods. Moreover, the region's diverse dietary habits and cultural preferences are fueling innovation in product development to cater to specific dietary needs.

Key players in the market

Some of the key players in Medical Foods market include Abbott Laboratories, Ajinomoto Cambrooke Inc, Alfasigma S.p.A., BioMarin Pharmaceutical, Cerecin Inc, Danone S.A., Fresenius SE & Co. KGaA, Mead Johnson, Meiji Holdings and Co Ltd, Metagenics Inc, Nestle S.A., Primus Pharmaceuticals Inc and Reckitt Benckiser Group plc.

Key Developments:

In May 2024, Danone has struck a deal to acquire Functional Formularies, a US whole foods tube-feeding business. The France-headquartered dairy giant has snapped up the Ohio-based company from private-equity business Swander Pace Capital for an undisclosed fee. The move has extended Danone's medical nutrition portfolio, through which it develops products for people with special medical needs, adding to its enteral tube-feeding ranges.

In January 2024, Abbott, a global leader in science-based nutrition, announced the launch of its new PROTALITY(TM) brand. The high-protein nutrition shake is the first product in this line to support the growing number of adults interested in pursuing weight loss while maintaining muscle mass and good nutrition.

Products Covered:

  • Oral Rehydration Products
  • Nutritionally Complete Formulas
  • Nutritionally Incomplete Formulas

Route of Administrations Covered:

  • Oral
  • Enteral

Sales Channels Covered:

  • Supermarkets & Hypermarkets
  • Retail Pharmacies
  • Drugs Stores
  • Online Sales
  • Institutional Sales (Hospital Pharmacies)

Nutritional Ingredients Covered:

  • Proteins
  • Vitamins and Minerals
  • Isoflavones
  • Omega-3
  • Phytosterols

Forms Covered:

  • Bars
  • Gels
  • Liquid
  • Powder
  • Tablets & Capsules
  • Other Forms

Age Groups Covered:

  • Adults
  • Adolescent
  • Weaning
  • Infants

Applications Covered:

  • Sleep Management
  • Neuro-Degenerative Disorders
  • Maple Syrup Urine Disease (MSUD)
  • Diabetes (Diabetic Neuropathy)
  • Cancer (Chemotherapy-Induced Diarrhea)
  • Attention Deficit Hyperactivity Disorder (ADHD)
  • Alzheimer's Disease
  • Chronic Conditions
  • Depression
  • Inborn Errors of Metabolism
  • Minimal Hepatic Encephalopathy
  • Neurological & Psychological Disorders
  • Nutritional Deficiency
  • Obesity and Hypertension
  • Ophthalmology
  • Pathogen Related Infections
  • Urea Cycle Disorders
  • Orphan Diseases
  • Tyrosinemia Types I And II
  • Propionic Acidemia
  • Pain Management
  • Organic Acidurias
  • Methylmalonic Acidemia
  • Isovaleric Acidemia
  • Homocystinuria
  • Gastrointestinal Disorders

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Medical Foods Market, By Product

  • 5.1 Introduction
  • 5.2 Oral Rehydration Products
  • 5.3 Nutritionally Complete Formulas
  • 5.4 Nutritionally Incomplete Formulas

6 Global Medical Foods Market, By Route of Administration

  • 6.1 Introduction
  • 6.2 Oral
  • 6.3 Enteral

7 Global Medical Foods Market, By Sales Channel

  • 7.1 Introduction
  • 7.2 Supermarkets & Hypermarkets
  • 7.3 Retail Pharmacies
  • 7.4 Drugs Stores
  • 7.5 Online Sales
  • 7.6 Institutional Sales (Hospital Pharmacies)

8 Global Medical Foods Market, By Nutritional Ingredient

  • 8.1 Introduction
  • 8.2 Proteins
  • 8.3 Vitamins and Minerals
  • 8.4 Isoflavones
  • 8.5 Omega-3
  • 8.6 Phytosterols

9 Global Medical Foods Market, By Form

  • 9.1 Introduction
  • 9.2 Bars
  • 9.3 Gels
  • 9.4 Liquid
  • 9.5 Powder
  • 9.6 Tablets & Capsules
  • 9.7 Other Forms

10 Global Medical Foods Market, By Age Group

  • 10.1 Introduction
  • 10.2 Adults
  • 10.3 Adolescent
  • 10.4 Weaning
  • 10.5 Infants

11 Global Medical Foods Market, By Application

  • 11.1 Introduction
  • 11.2 Sleep Management
  • 11.3 Neuro-Degenerative Disorders
  • 11.4 Maple Syrup Urine Disease (MSUD)
  • 11.5 Diabetes (Diabetic Neuropathy)
  • 11.6 Cancer (Chemotherapy-Induced Diarrhea)
  • 11.7 Attention Deficit Hyperactivity Disorder (ADHD)
  • 11.8 Alzheimer's Disease
  • 11.9 Chronic Conditions
  • 11.10 Depression
  • 11.11 Inborn Errors of Metabolism
  • 11.12 Minimal Hepatic Encephalopathy
  • 11.13 Neurological & Psychological Disorders
  • 11.14 Nutritional Deficiency
  • 11.15 Obesity and Hypertension
  • 11.16 Ophthalmology
  • 11.17 Pathogen Related Infections
  • 11.18 Urea Cycle Disorders
  • 11.19 Orphan Diseases
    • 11.19.1 Eosinophilic Esophagitis
    • 11.19.2 Phenylketonuria
    • 11.19.3 Food Protein-Induced Enterocolitis Syndrome (FPIES)
  • 11.20 Tyrosinemia Types I And II
  • 11.21 Propionic Acidemia
  • 11.22 Pain Management
  • 11.23 Organic Acidurias
  • 11.24 Methylmalonic Acidemia
  • 11.25 Isovaleric Acidemia
  • 11.26 Homocystinuria
  • 11.27 Gastrointestinal Disorders

12 Global Medical Foods Market, By Geography

  • 12.1 Introduction
  • 12.2 North America
    • 12.2.1 US
    • 12.2.2 Canada
    • 12.2.3 Mexico
  • 12.3 Europe
    • 12.3.1 Germany
    • 12.3.2 UK
    • 12.3.3 Italy
    • 12.3.4 France
    • 12.3.5 Spain
    • 12.3.6 Rest of Europe
  • 12.4 Asia Pacific
    • 12.4.1 Japan
    • 12.4.2 China
    • 12.4.3 India
    • 12.4.4 Australia
    • 12.4.5 New Zealand
    • 12.4.6 South Korea
    • 12.4.7 Rest of Asia Pacific
  • 12.5 South America
    • 12.5.1 Argentina
    • 12.5.2 Brazil
    • 12.5.3 Chile
    • 12.5.4 Rest of South America
  • 12.6 Middle East & Africa
    • 12.6.1 Saudi Arabia
    • 12.6.2 UAE
    • 12.6.3 Qatar
    • 12.6.4 South Africa
    • 12.6.5 Rest of Middle East & Africa

13 Key Developments

  • 13.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 13.2 Acquisitions & Mergers
  • 13.3 New Product Launch
  • 13.4 Expansions
  • 13.5 Other Key Strategies

14 Company Profiling

  • 14.1 Abbott Laboratories
  • 14.2 Ajinomoto Cambrooke Inc
  • 14.3 Alfasigma S.p.A.
  • 14.4 BioMarin Pharmaceutical
  • 14.5 Cerecin Inc
  • 14.6 Danone S.A.
  • 14.7 Fresenius SE & Co. KGaA
  • 14.8 Mead Johnson
  • 14.9 Meiji Holdings and Co Ltd
  • 14.10 Metagenics Inc
  • 14.11 Nestle S.A.
  • 14.12 Primus Pharmaceuticals Inc
  • 14.13 Reckitt Benckiser Group plc

List of Tables

  • Table 1 Global Medical Foods Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Medical Foods Market Outlook, By Product (2022-2030) ($MN)
  • Table 3 Global Medical Foods Market Outlook, By Oral Rehydration Products (2022-2030) ($MN)
  • Table 4 Global Medical Foods Market Outlook, By Nutritionally Complete Formulas (2022-2030) ($MN)
  • Table 5 Global Medical Foods Market Outlook, By Nutritionally Incomplete Formulas (2022-2030) ($MN)
  • Table 6 Global Medical Foods Market Outlook, By Route of Administration (2022-2030) ($MN)
  • Table 7 Global Medical Foods Market Outlook, By Oral (2022-2030) ($MN)
  • Table 8 Global Medical Foods Market Outlook, By Enteral (2022-2030) ($MN)
  • Table 9 Global Medical Foods Market Outlook, By Sales Channel (2022-2030) ($MN)
  • Table 10 Global Medical Foods Market Outlook, By Supermarkets & Hypermarkets (2022-2030) ($MN)
  • Table 11 Global Medical Foods Market Outlook, By Retail Pharmacies (2022-2030) ($MN)
  • Table 12 Global Medical Foods Market Outlook, By Drugs Stores (2022-2030) ($MN)
  • Table 13 Global Medical Foods Market Outlook, By Online Sales (2022-2030) ($MN)
  • Table 14 Global Medical Foods Market Outlook, By Institutional Sales (Hospital Pharmacies) (2022-2030) ($MN)
  • Table 15 Global Medical Foods Market Outlook, By Nutritional Ingredient (2022-2030) ($MN)
  • Table 16 Global Medical Foods Market Outlook, By Proteins (2022-2030) ($MN)
  • Table 17 Global Medical Foods Market Outlook, By Vitamins and Minerals (2022-2030) ($MN)
  • Table 18 Global Medical Foods Market Outlook, By Isoflavones (2022-2030) ($MN)
  • Table 19 Global Medical Foods Market Outlook, By Omega-3 (2022-2030) ($MN)
  • Table 20 Global Medical Foods Market Outlook, By Phytosterols (2022-2030) ($MN)
  • Table 21 Global Medical Foods Market Outlook, By Form (2022-2030) ($MN)
  • Table 22 Global Medical Foods Market Outlook, By Bars (2022-2030) ($MN)
  • Table 23 Global Medical Foods Market Outlook, By Gels (2022-2030) ($MN)
  • Table 24 Global Medical Foods Market Outlook, By Liquid (2022-2030) ($MN)
  • Table 25 Global Medical Foods Market Outlook, By Powder (2022-2030) ($MN)
  • Table 26 Global Medical Foods Market Outlook, By Tablets & Capsules (2022-2030) ($MN)
  • Table 27 Global Medical Foods Market Outlook, By Other Forms (2022-2030) ($MN)
  • Table 28 Global Medical Foods Market Outlook, By Age Group (2022-2030) ($MN)
  • Table 29 Global Medical Foods Market Outlook, By Adults (2022-2030) ($MN)
  • Table 30 Global Medical Foods Market Outlook, By Adolescent (2022-2030) ($MN)
  • Table 31 Global Medical Foods Market Outlook, By Weaning (2022-2030) ($MN)
  • Table 32 Global Medical Foods Market Outlook, By Infants (2022-2030) ($MN)
  • Table 33 Global Medical Foods Market Outlook, By Application (2022-2030) ($MN)
  • Table 34 Global Medical Foods Market Outlook, By Sleep Management (2022-2030) ($MN)
  • Table 35 Global Medical Foods Market Outlook, By Neuro-Degenerative Disorders (2022-2030) ($MN)
  • Table 36 Global Medical Foods Market Outlook, By Maple Syrup Urine Disease (MSUD) (2022-2030) ($MN)
  • Table 37 Global Medical Foods Market Outlook, By Diabetes (Diabetic Neuropathy) (2022-2030) ($MN)
  • Table 38 Global Medical Foods Market Outlook, By Cancer (Chemotherapy-Induced Diarrhea) (2022-2030) ($MN)
  • Table 39 Global Medical Foods Market Outlook, By Attention Deficit Hyperactivity Disorder (ADHD) (2022-2030) ($MN)
  • Table 40 Global Medical Foods Market Outlook, By Alzheimer's Disease (2022-2030) ($MN)
  • Table 41 Global Medical Foods Market Outlook, By Chronic Conditions (2022-2030) ($MN)
  • Table 42 Global Medical Foods Market Outlook, By Depression (2022-2030) ($MN)
  • Table 43 Global Medical Foods Market Outlook, By Inborn Errors of Metabolism (2022-2030) ($MN)
  • Table 44 Global Medical Foods Market Outlook, By Minimal Hepatic Encephalopathy (2022-2030) ($MN)
  • Table 45 Global Medical Foods Market Outlook, By Neurological & Psychological Disorders (2022-2030) ($MN)
  • Table 46 Global Medical Foods Market Outlook, By Nutritional Deficiency (2022-2030) ($MN)
  • Table 47 Global Medical Foods Market Outlook, By Obesity and Hypertension (2022-2030) ($MN)
  • Table 48 Global Medical Foods Market Outlook, By Ophthalmology (2022-2030) ($MN)
  • Table 49 Global Medical Foods Market Outlook, By Pathogen Related Infections (2022-2030) ($MN)
  • Table 50 Global Medical Foods Market Outlook, By Urea Cycle Disorders (2022-2030) ($MN)
  • Table 51 Global Medical Foods Market Outlook, By Orphan Diseases (2022-2030) ($MN)
  • Table 52 Global Medical Foods Market Outlook, By Eosinophilic Esophagitis (2022-2030) ($MN)
  • Table 53 Global Medical Foods Market Outlook, By Phenylketonuria (2022-2030) ($MN)
  • Table 54 Global Medical Foods Market Outlook, By Food Protein-Induced Enterocolitis Syndrome (FPIES) (2022-2030) ($MN)
  • Table 55 Global Medical Foods Market Outlook, By Tyrosinemia Types I And II (2022-2030) ($MN)
  • Table 56 Global Medical Foods Market Outlook, By Propionic Acidemia (2022-2030) ($MN)
  • Table 57 Global Medical Foods Market Outlook, By Pain Management (2022-2030) ($MN)
  • Table 58 Global Medical Foods Market Outlook, By Organic Acidurias (2022-2030) ($MN)
  • Table 59 Global Medical Foods Market Outlook, By Methylmalonic Acidemia (2022-2030) ($MN)
  • Table 60 Global Medical Foods Market Outlook, By Isovaleric Acidemia (2022-2030) ($MN)
  • Table 61 Global Medical Foods Market Outlook, By Homocystinuria (2022-2030) ($MN)
  • Table 62 Global Medical Foods Market Outlook, By Gastrointestinal Disorders (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.